M&T Bank Corp Accelerate Diagnostics, Inc Transaction History

M&T Bank Corp

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$7.04 - $11.7 $94,089 - $156,370	-13,365 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$9.98 - $18.04 $29,530 - $53,380	2,959 Added 28.44%	13,365 $142,000
Q1 2020 May 14, 2020	SELL	$4.62 - $18.74 $272 - $1,105	-59 Reduced 0.56%	10,406 $87,000
Q4 2019 Feb 07, 2020	BUY	$14.6 - $18.13 $152,789 - $189,730	10,465 New	10,465 $177,000
Q3 2019 Nov 12, 2019	SELL	$16.62 - $23.92 $150,111 - $216,045	-9,032 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$17.79 - $22.88 $160,679 - $206,652	9,032 New	9,032 $206,000

549K

Ticker AXDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 99,059,904
Market Cap $191M
Description
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious ...

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.